This is a StreetInsider.com Premium Only Page

Infinity Pharma (INFI) –

Nov 20, 2023 08:47 AM Form 25-NSE INFINITY PHARMACEUTICALS Filed by: Nasdaq Stock Market LLC

Oct 8, 2023 09:00 PM INFINITY ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Infinity Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

Oct 2, 2023 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Applied Digital, Infinity, and Shift4 and Encourages Investors to Contact the Firm

Sep 29, 2023 04:04 PM Form 8-K INFINITY PHARMACEUTICALS For: Sep 28

Sep 28, 2023 05:00 PM ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – INF

Sep 27, 2023 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Live Nation, Applied Digital, and Infinity and Encourages Investors to Contact the Firm

Sep 22, 2023 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Infinity, Shift4, and Comerica and Encourages Investors to Contact the Firm

Sep 17, 2023 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Infinity, Shift4, and Comerica and Encourages Investors to Contact the Firm

Sep 17, 2023 04:49 PM ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INFI

Sep 13, 2023 08:11 AM Form 8-K INFINITY PHARMACEUTICALS For: Sep 12

Sep 12, 2023 08:15 PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INFI

Sep 12, 2023 06:21 PM Form 4 INFINITY PHARMACEUTICALS For: Sep 08 Filed by: Perkins Adelene Q

Sep 12, 2023 02:30 AM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bausch, Applied Digital, and Infinity and Encourages Investors to Contact the Firm

Sep 11, 2023 04:09 PM Form 8-K INFINITY PHARMACEUTICALS For: Sep 05

Sep 6, 2023 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Infinity, HUB, and Shift4 and Encourages Investors to Contact the Firm

Sep 6, 2023 03:36 PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INFI

Sep 1, 2023 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Applied Digital, Infinity, and HUB and Encourages Investors to Contact the Firm

Sep 1, 2023 04:07 PM Form 8-K INFINITY PHARMACEUTICALS For: Aug 29

Aug 27, 2023 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Infinity, HUB, and Shift4 and Encourages Investors to Contact the Firm

Aug 21, 2023 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Applied Digital and Infinity and Encourages Investors to Contact the Firm

Aug 10, 2023 04:33 PM Form 10-Q INFINITY PHARMACEUTICALS For: Jun 30

Jul 25, 2023 04:30 PM Form 8-K INFINITY PHARMACEUTICALS For: Jul 24

Jul 25, 2023 04:07 PM Infinity Pharma (INFI) Announces Value Preservation and Maximization Plan

Jul 25, 2023 04:05 PM Infinity Pharmaceuticals Announces Value Preservation and Maximization Plan

Jul 24, 2023 08:36 AM Form 8-K INFINITY PHARMACEUTICALS For: Jul 23

Jul 24, 2023 08:32 AM Infinity Pharma (INFI) Announces Termination of Merger Agreement with MEI Pharma (MEIP)

Jul 24, 2023 08:30 AM Infinity Pharmaceuticals Announces Termination of Merger Agreement with MEI Pharma

Jul 19, 2023 08:00 AM MEI Pharma Reminds Shareholders to Vote Today FOR the Infinity Transaction

Jul 17, 2023 08:00 AM MEI Pharma Encourages Shareholders to Vote FOR the Infinity Transaction

Jul 14, 2023 04:31 PM Form 8-K INFINITY PHARMACEUTICALS For: Jul 14

Jul 14, 2023 01:00 PM Infinity Pharma (INFI) Announces Shareholder Approval of Merger with MEI Pharma

Jul 14, 2023 01:00 PM Infinity Pharmaceuticals Announces Stockholder Approval of Merger with MEI Pharma

Jul 11, 2023 08:00 AM MEI Pharma Provides Final Reminder to Shareholders to Vote Today FOR the Merger With Infinity Pharmaceuticals

Jul 10, 2023 08:31 AM Form DEFA14A INFINITY PHARMACEUTICALS

Jul 10, 2023 08:30 AM Infinity Pharmaceuticals Provides Additional Information on MARIO-8 Study Evaluating Eganelisib in Combination with the PD-1 Targeted Checkpoint Inhibitor Pembrolizumab (KEYTRUDA®) in Patients with S

Jul 7, 2023 08:00 AM MEI Pharma Reminds Shareholders to Vote FOR the Merger with Infinity Pharmaceuticals

Jul 5, 2023 08:34 AM ISS Recommends Infinity Pharmaceuticals (INFI) Stockholders Vote FOR the Merger with MEI Pharma, Inc. (MEIP)

Jul 5, 2023 08:31 AM Form DEFA14A INFINITY PHARMACEUTICALS

Jul 5, 2023 08:30 AM ISS Recommends Infinity Pharmaceuticals Stockholders Vote FOR the Merger with MEI Pharma, Inc.

Jul 5, 2023 08:00 AM MEI Pharma Highlights Recommendation by Leading Independent Proxy Advisory Firm ISS to Vote “FOR” Pending Transaction with Infinity Pharmaceuticals

Jul 3, 2023 04:58 PM Form 425 INFINITY PHARMACEUTICALS Filed by: INFINITY PHARMACEUTICALS, INC.

Jul 3, 2023 04:56 PM Form 8-K INFINITY PHARMACEUTICALS For: Jul 03

Jul 3, 2023 08:31 AM Form DEFA14A INFINITY PHARMACEUTICALS

Jun 30, 2023 04:31 PM Form 8-K INFINITY PHARMACEUTICALS For: Jun 27

Jun 29, 2023 08:02 AM MEI Pharma (MEIP) Issues Letter to Shareholders

Jun 29, 2023 08:00 AM MEI Pharma Mails Letter to Shareholders Reiterating Value Creating Potential of Proposed Transaction with Infinity Pharmaceuticals

Jun 29, 2023 06:06 AM Form DEFA14A INFINITY PHARMACEUTICALS

Jun 27, 2023 08:31 AM Form DEFA14A INFINITY PHARMACEUTICALS

Jun 21, 2023 08:32 AM Form DEFA14A INFINITY PHARMACEUTICALS

Jun 20, 2023 08:31 AM Form DEFA14A INFINITY PHARMACEUTICALS